AmpliTech Q2 loss widens to $3.09m as heavy R&D spending offsets revenue beat
AmpliTech Group Inc. (NASDAQ: AMPG) reported Q2 2026 net loss of $3.09m, or 12 cents/share, wider than the expected loss of 2 cents/share, after revenue beat consensus. Revenue rose to $8.07m, above $8.00m, up 50.9% sequentially. R&D more than doubled to $1.37m, while gross profit rose to $2.25m.
How this was made
The 30-second read
Why it matters
Traders should focus on whether the gross margin improvement translates into operating leverage in subsequent quarters, and how quickly commercialization spend converts into sustained order intake and revenue.
Market read
A premarket selloff is justified by the wider-than-expected net loss, but the revenue beat, gross margin surge, and July order flow provide offsetting positives.
What to watch
Follow-on orders of over $6m in July, including nearly $4m tied to a prior LOI, could support revenue conversion even as near-term losses widen.
Background
AmpliTech’s Q2 2026 results show a divergence: revenue beat and gross margin expansion versus a larger net loss from higher R&D and SG&A.
Ticker impact
AmpliTech reported Q2 net loss of $3.09m, wider than expected, while revenue beat to $8.07m and R&D more than doubled to $1.37m.
Near-term downside bias likely as investors weigh the loss widening against improving gross margin and the need for continued commercialization spend.
The article provides concrete P&L deltas (net loss, R&D, gross margin) plus liquidity and capital actions (Series A rights proceeds) that can influence the next few quarters’ risk/reward.
Market effects
Highlights the tradeoff in RF/5G equipment names between gross margin improvement and continued heavy R&D burn for commercialization.
No specific regional macro linkage beyond general small-cap tech sentiment.
Limited; story is company-specific to 5G O-RAN, MMIC, and RF/microwave components.
Counterpoint
The gross margin jump to 27.9% suggests production efficiency is improving, and the $20.12m net Series A rights proceeds may fund commercialization without immediate dilution pressure.
Key entities
- public_companyAmpliTech Group Inc.
NASDAQ-listed RF and microwave components and systems provider reporting Q2 2026 results and capital actions.
- counterpartyMaxim Group LLC
Terminated equity distribution agreement referenced in the company’s post-quarter strategic moves.
- customerNorth American mobile network operator
Referenced as the source of nearly $4m of follow-on orders under a prior Letter of Intent.
